RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 57.09% | 57.05% | 60.46% | 64.10% | -191.92% |
| Total Depreciation and Amortization | -20.61% | -17.50% | 4.26% | 28.05% | 54.11% |
| Total Amortization of Deferred Charges | -97.84% | -- | -- | -- | 0.00% |
| Total Other Non-Cash Items | -78.46% | -79.05% | -78.55% | -83.43% | 10,357.17% |
| Change in Net Operating Assets | -137.31% | 355.78% | -504.68% | -623.73% | -122.77% |
| Cash from Operations | 6.60% | 19.78% | 27.03% | 29.07% | 12.56% |
| Capital Expenditure | -635.90% | -109.09% | -133.33% | 65.28% | 94.08% |
| Sale of Property, Plant, and Equipment | 173.94% | 173.94% | 28.25% | 295.07% | 73.27% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -76.12% | -39.04% | -44.92% | -59.29% | 449.23% |
| Cash from Investing | 110.49% | 115.15% | 112.06% | 110.74% | -386.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 27.88% | 20.34% | -1.59% | -77.39% | -809.76% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 22.38% | 22.38% | 20.34% | 20.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 126.23% | 123.00% | 200.00% | 200.00% | -4,528.57% |
| Cash from Financing | 60.07% | 76.79% | 6.87% | -15.96% | -100.32% |
| Foreign Exchange rate Adjustments | 0.00% | -62.32% | -101.63% | -60.95% | 512.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.82% | 42.18% | 36.46% | 39.38% | -3.80% |
